[CADL] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CADL] Candel Therapeutics, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 12.26%
YoY- 0.71%
Quarter Report
CADL's Result
CADL's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 0 31 31 31 -
PBT -10,646 -8,435 -8,688 -16,162 -2,554 42.85%
Tax 0 -90 -193 14 154 -
NP -10,646 -8,435 -8,495 -16,162 -2,554 42.85%
Tax Rate - - - - - -
Total Cost 10,646 8,435 8,526 16,193 2,585 42.42%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 0.00 -27,403.23 -52,135.48 -8,238.71 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.33 -0.29 -0.29 -0.69 -0.14 23.88%
EPS Diluted -0.33 -0.29 -0.29 -0.69 -0.14 23.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.